Skip to main content
Innate Pharma S.A. (EPA: IPH)
France flag France · Delayed Price · Currency is EUR
2.090
-0.020 (-0.95%)
Aug 30, 2024, 5:35 PM CET

Innate Pharma Revenue

Innate Pharma had revenue of 165.52M EUR in the half year ending February 29, 2024, with 81.11% growth. This brings the company's revenue in the last twelve months to 331.52M, up 36.80% year-over-year. In the fiscal year ending August 31, 2023, Innate Pharma had annual revenue of 278.34M with 25.72% growth.

Revenue (ttm)
331.52M
Revenue Growth
+36.80%
P/S Ratio
2.73
Revenue / Employee
344.36K
Employees
179
Market Cap
169.19M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2023278.34M56.94M25.72%
Aug 31, 2022221.40M17.43M8.55%
Aug 31, 2021203.97M29.41M16.85%
Aug 31, 2020174.56M-34.47M-16.49%
Aug 31, 2019209.03M70.70M51.11%
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Aug 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Innate Pharma News

More News